Literature DB >> 10543346

Pubic osteomyelitis and granuloma after bone anchor placement.

M P FitzGerald1, S Gitelis, L Brubaker.   

Abstract

The use of bone anchors as a superior fixation for suburethral slings is becoming popular. We present a case report of pubic osteomyelitis and granuloma after bone anchor placement. A 71-year-old woman underwent placement of a vaginal wall sling using pubic bone anchors placed through a suprapubic incision. Recurrent swelling of the mons pubis required re-exploration and removal of the anchors from an infected pubic bone. When symptoms persisted over the following 10 months, the patient underwent repeat surgery and excision of a pubic bone granuloma. The use of bone anchors in suburethral sling surgery is associated with possible increase in patient morbidity, and no benefit to the patient has been shown.

Entities:  

Mesh:

Year:  1999        PMID: 10543346     DOI: 10.1007/s001929970014

Source DB:  PubMed          Journal:  Int Urogynecol J Pelvic Floor Dysfunct


  5 in total

1.  Lessons from the past: directions for the future. Do new marketed surgical procedures and grafts produce ethical, personal liability, and legal concerns for physicians?

Authors:  Donald R Ostergard
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  2007-03-16

Review 2.  Complications of anterior compartment vaginal surgery.

Authors:  Eric S Rovner
Journal:  Curr Urol Rep       Date:  2007-09       Impact factor: 3.092

3.  Actinomyces meyeri osteomyelitis of the symphysis pubis following pubovaginal sling.

Authors:  Jaime B Long; Joseph M Collins; Christopher P Beauchamp; Rosanne Kho; Jeffrey L Cornella
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  2007-04-03

Review 4.  Treatment of urinary incontinence.

Authors:  E S Rovner
Journal:  Curr Urol Rep       Date:  2000-10       Impact factor: 3.092

Review 5.  A transperitoneal laparoscopic approach to endourology.

Authors:  A M Kaynan; H N Winfield
Journal:  Curr Urol Rep       Date:  2001-04       Impact factor: 2.862

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.